e8vk
 

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) April 26, 2005

Bone Care International, Inc.

(Exact Name of Registrant as Specified in Its Charter)

         
Wisconsin
(State or Other Jurisdiction
of Incorporation)
  0-27854
(Commission
File Number)
  39-1527471
(IRS Employer
Identification No.)
 
1600 Aspen Commons, Suite 900
Middleton, Wisconsin
(Address of Principal Executive Offices)
      53562
(Zip Code)

(608) 662-7800

(Registrant’s Telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting materials pursuant to Rule 14a-12 under the Exchange Act (CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (CFR 240.13e-4(c))
 
 

 


 

Item 2.02. Results of Operations and Financial Condition.

     On April 26, 2005 the Company issued a press release reporting its third quarter fiscal year 2005 financial results, a copy of which is filed Exhibit 99.1.

Item 9.01. Exhibits

       
Exhibits:
 
 
99.1
      Press Release dated March 26, 2005.

 


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has fully cased this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
  BONE CARE INTERNATIONAL, INC.


 
 
Date: April 26, 2005 By:   /s/ Brian J. Hayden    
    Brian J. Hayden   
    VP Finance   

 


 

         

EXHIBIT INDEX

     The following exhibits are filed herewith:

       
Exhibit No.   Description  
99.1
  Press Release issued by the Company